Past Global Health Events
-
Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation
In this seminar, NCI K08 Awardee Dr. Gibson will discuss his research from the following publication: Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation.
-
World Cancer Day 2023 Seminar: Global Cancer Solutions to Address the Cancer Burden in Africa and Beyond
Register and join a World Cancer Day Panel hosted by the Department of Epidemiology, at the Johns Hopkins Bloomberg School of Public Health. A keynote address will be given by Wilfred Ngwa, PhD, MSc Chair of the Lancet Oncology Commission for Sub-Saharan Africa, Associate Professor of Radiation Oncology & Molecular Radiation Sciences, Johns Hopkins Medicine.
-
London Global Cancer Week: Utilizing Cancer Research Funding to Inform Action and Drive Collaboration
NCI/CGH recognizes the importance of working in collaboration with researchers and research funding partners to track, share, and encourage utilization of data, to drive global cancer research and control action. This session will give an overview of three efforts to map and track global cancer research and research funding, led by the International Cancer Research Partnership (ICRP), World View (formerly World Report) hosted by the National institutes of Health, and the NCI/CGH through the Global Oncology Survey of NCI-Designated Cancer Centers.
-
International Cancer Screening Network (ICSN) Colorectal Cancer Screening Webinar
ICSN has will host an interactive webinar and panel discussion entitled, "The Impact of COVID-19 on Colorectal Cancer (CRC) Screening Activity: Results from the Survey on 2020 Activity and Modeling their Impact on Long-term CRC Incidence and Mortality." The agenda focuses on survey data, and results of simulation modeling from the International Partnership for Resilience in Cancer Systems (I-PaRCS) on the impact of the observed disruptions on long-term CRC incidence and mortality; and qualitative analysis of the characteristics of programs showing a more effective response to the pandemic.
-
The 18th International Conference on Malignancies in HIV/AIDS
Join NCI's Office of HIV and AIDS Malignancy (OHAM) at the 18th International Conference on Malignancies in HIV/AIDS (ICMH). The 3-day conference, sponsored by OHAM, focuses on the presentation of basic, epidemiologic, and clinical aspects of research on malignancies in HIV-infected individuals; and enables information exchange between laboratory and clinically based investigators to decrease the interval between basic discovery and clinical application. ICMH is organized to provide informational and networking resources for people in the U.S. and globally, participating in malignancy research in HIV/AIDS and in tumor virology.
-
2022 World Cancer Congress
The National Cancer Institute (NCI) is convening several pre-recorded and in-person scientific sessions at the Union for International Cancer Control (UICC) 2022 World Cancer Congress, October 18-20, 2022 in Geneva, Switzerland, and through an online digital platform.
-
NIH’s Support of Early Career Scientists in Global Cancer Research: Current State and New Opportunities
On Wednesday, October 12, join panelists Dr. Sudha Sivaram, NCI Center for Global Health, and Dr. Sergey Radaev, NCI Center for Cancer Training, for a workshop on NIH’s Support of Early Career Scientists in Global Cancer Research: Current State and New Opportunities, at the the 2022 International Cancer Education Conference (ICEC).
-
Global Cancer Stigma Research Workshop
Dr. Satish Gopal gave opening remarks at the National Cancer Institute's (NCI) Global Cancer Stigma Research Workshop. The 2-day workshop was sponsored by NCI's Center for Global Health (CGH) and Division of Cancer Control and Population Sciences (DCCPS), and focused on the impact of stigma on global cancer control, and the domestic and global cancer stigma research conducted by NIH/NCI grantees. Participants explored research gaps for measuring stigma and developing context-specific stigma reduction interventions within the cancer care continuum in diverse global settings.
-
World Cancer Research Day: First Lady Jill Biden and Letizia, Queen of Spain, visit Herbert Irving Comprehensive Cancer Center
First Lady Jill Biden and Letizia, Queen of Spain, visit Herbert Irving Comprehensive Cancer Center (HICCC), at Columbia University Medical Center, New York, NY; in support of World Cancer Research Day 2022.
-
Pre-Application Webinar for RFA-CA-22-019, Global Implementation Science for Equitable Cancer Control (GlobalISE Cancer Control)
The National Cancer Institute (NCI) held a pre-application webinar for the Funding Opportunity Announcement (FOA) RFA-CA-22-019, “Global Implementation Science for Equitable Cancer Control (GlobalISE Cancer Control, U54 Clinical Trial Optional).”